Mimedx (MDXG) Gains from Investment Securities (2010 - 2026)

Mimedx has disclosed Gains from Investment Securities across 15 years of filings, most recently posting $1.9 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $1.9 million, down 22.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 639.24% YoY), and the FY2025 annual result was $3.1 million, up 8057.89% from the prior year.
• Gains from Investment Securities came in at $1.9 million for Q1 2026 at Mimedx, down from $3.1 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $3.1 million in Q4 2025 to a low of -$2.5 million in Q3 2024.
• The 5-year median for Gains from Investment Securities is $240500.0 (2023), against an average of $537785.7.
• Across the five-year window, Gains from Investment Securities jumped 16914.29% in 2022 and sank 15618.75% in 2024, its largest moves.
• Mimedx's Gains from Investment Securities stood at $1.1 million in 2022, then slumped by 88.18% to $132000.0 in 2023, then plunged by 84.85% to $20000.0 in 2024, then soared by 15400.0% to $3.1 million in 2025, then slumped by 38.68% to $1.9 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.9 million (Q1 2026), $3.1 million (Q4 2025), and -$2.5 million (Q2 2025), per Business Quant data.